Biomedicine and diseases: The Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis

Cellular and Molecular Life Sciences

Volumn 62, Issue 13, 2005, Pages 1434-1447

  Timur, A A ^a   Driscoll, D J ^b   Wang, Q ^a,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

AGGF1; Angiogenesis; Blood vessels; Klippel Trenaunay syndrome (KTS); Vascular anomalies and malformations; Vasculogenesis; VG5Q

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIC FACTOR WITH G PATCH AND FHA DOMAINS 1; ANGIOPOIETIN RECEPTOR; COLLAGEN TYPE 3; ENDOGLIN; GLOMULIN; KRIT1 PROTEIN; MGC4607 PROTEIN; NDP PROTEIN; NORRIE DISEASE PROTEIN; NOTCH3 RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PROTEIN; SMAD4 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ACVRLK1 GENE; ANGIOGENESIS; ANGIOOSTEOHYPERTROPHY SYNDROME; CADASIL; CELL DIFFERENTIATION; CHROMOSOME 10Q; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME 22Q; CHROMOSOME 3Q; CHROMOSOME 5Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME XQ; CLINICAL FEATURE; COL3A1 GENE; CONGENITAL BLOOD VESSEL MALFORMATION; COWDEN SYNDROME; CYTOGENETICS; EHLERS DANLOS SYNDROME; EMBRYO DEVELOPMENT; EXUDATIVE RETINITIS; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GLOMUS TUMOR; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HEMATOPOIETIC CELL; HUMAN; MACROCEPHALY; MADH4 GENE; MILROY DISEASE; MORPHOGENESIS; MULTIPLE CANCER; NEVUS FLAMMEUS; NUCLEAR FACTOR KAPPA B ESSENTIAL MODULATOR GENE; PATHOGENESIS; POLYPOSIS; PROGRAMMED CELL DEATH 10 GENE; RETINA MACULA DEGENERATION; REVIEW; SERVELLE MARTORELL SYNDROME; SIGNAL TRANSDUCTION; SRY TYPE HIGH MOBILITY GROUP BOX GENE; TELANGIECTASIA;

ANGIOGENIC PROTEINS; CARDIOVASCULAR ABNORMALITIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KLIPPEL-TRENAUNAY-WEBER SYNDROME; LYMPHANGIOGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 21544474701     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-005-4523-7     Document Type: Review

References (112)

1. Carmeliet P. (2003) Angiogenesis in health and disease. Nat. Med. 9: 653-660
2. Bazzoni G. and Dejana E. (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 84: 869-901
3. Kahn H. J., Bailey D. and Marks A. (2002) Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiocarcinomas. Mod. Pathol. 15: 434-440
4. Al-Rawi M. A., Mansel R. E. and Jiang W. G. (2005) Molecular and cellular mechanisms of lymphangiogenesis. Eur. J. Surg. Oncol. 31: 117-121
5. Baron M. (2001) Induction of embryonic hematopoietic and endothelial stem/progenitor cells by hedgehog-mediated signals. Differentiation 68: 175-185
6. Choi K. (2002) The hemangioblast: a common progenitor of hematopoietic and endothelial cells. J. Hematother. Stem Cell Res. 11: 91-101
7. Tang D. G. and Conti C. J. (2004) Endothelial cell development, vasculogenesis, angiogenesis and tumor neovascularization: an update. Semin. Thromb. Hemost. 30: 109-117
8. Lawson N. D., Scheer N., Pham V. N., Kim C. H., Chitnis A. B., Campos-Ortega J. A. et al. (2001) Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128: 3675-3683
9. Shawber C. J. and Kitajewski J. (2004) Notch function in the vasculature: insights from zebrafish, mouse and man. Bioessays 26: 225-234
10. Zhong T. P., Childs S., Leu J. P. and Fishman M. C. (2001) Gridlock signalling pathway fashions the first embryonic artery. Nature 414: 216-220
11. Wang H. U., Chen Z. F. and Anderson D. J. (1998) Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93: 741-753
12. Adams R. H., Wilkinson G. A., Weiss C., Diella F., Gale N. W., Deutsch U. et al. (1999) Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis and sprouting angiogenesis. Genes Dev. 13: 295-306
13. Zhang X. Q., Takakura N., Oike Y., Inada T., Gale N. W., Yancopoulos G. D. et al. (2001) Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2(+) endothelial cells. Blood 98: 1028-1037
14. Carmeliet P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6: 389-395
15. Pugh C. W. and Ratcliffe P. J. (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9: 677-684
16. Scappaticci F. A. (2002) Mechanisms and future directions for angiogenesis-based cancer therapies. J. Clin. Oncol. 20: 3906-3927
17. Jain R. K. (2003) Molecular regulation of vessel maturation. Nat. Med. 9: 685-693
18. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K. S. et al. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442
19. Shalaby F., Rossant J., Yamaguchi T. P., Gertsenstein M., Wu X. F., Breitman M. L. et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66
20. Fong G. H., Rossant J., Gertsenstein M. and Breitman M. L. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70
21. Silvestre J. S., Tamarat R., Ebrahimian T. G., Le-Roux A., Clergue M., Emmanuel F. et al. (2003) Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ. Res. 93: 114-123
22. Dumont D. J., Gradwohl G., Fong G. H., Puri M. C., Gertsenstein M., Auerbach A. et al. (1994) Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8: 1897-1909
23. Jones N. and Dumont D. J. (2000) Tek/Tie2 signaling: new and old partners. Cancer Metastasis Rev. 19: 13-17
24. Maisonpierre P. C., Suri C., Jones P. F., Bartunkova S., Wiegand S. J., Radziejewski et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60
25. Sato T. N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-Maguire M. et al. (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74
26. Suri C., Jones P. F., Patan S., Bartunkova S., Maisonpierre P. C., Davis S. et al. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 1171-1180
27. Suri C., McClain J., Thurston G., McDonald D. M., Zhou H., Oldmixon E. H. et al. (1998) Increased vascularization in mice overexpressing angiopoietin-1. Science 282: 468-471
28. Jimenez B., Volpert O. V., Crawford S. E., Febbraio M., Silverstein R. L. and Bouck N. (2000) Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 6: 41-48
29. Nor J. E., Mitra R. S., Sutorik M. M., Mooney D. J., Castle V. P. and Polverini P. J. (2000) Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J. Vasc. Res. 37: 209-218
30. Chavakis E. and Dimmeler S. (2002) Regulation of endothelial cell survival and apoptosis during angiogenesis. Arterioscler. Thromb. Vasc. Biol. 22: 887-893
31. Volpert O. V., Zaichuk T., Zhou W., Reiher F., Ferguson T. A., Stuart P. M. et al. (2002) Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat. Med. 8: 349-357
32. Tonini T., Rossi F. and Claudio P. P. (2003) Molecular basis of angiogenesis and cancer. Oncogene 22: 6549-6556
33. Qi J. H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L. et al. (2003) A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 9: 407-415
34. Scavelli C., Weber E., Agliano M., Cirulli T., Nico B., Vacca A. et al. (2004) Lymphatics at the crossroads of angiogenesis and lymphangiogenesis. J. Anat. 204: 433-449
35. Taipale J., Makinen T., Arighi E., Kukk E., Karkkainen M. and Alitalo K. (1999) Vascular endothelial growth factor receptor-3. Curr. Top. Microbiol. Immunol. 237: 85-96
36. Wigle J. T. and Oliver G. (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98: 769-778
37. Jain R. K. and Padera T. P. (2003) Development. Lymphatics make the break. Science 299: 209-210
38. Yuan L., Moyon D., Pardanaud L., Breant C., Karkkainen M. J., Alitalo K. et al. (2002) Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129: 4797-4806
39. Kim H. and Dumont D. J. (2003) Molecular mechanisms in lymphangiogenesis: model systems and implications in human disease. Clin. Genet. 64: 282-292
40. Lohela M., Saaristo A., Veikkola T. and Alitalo K. (2003) Lymphangiogenic growth factors, receptors and therapies. Thromb. Haemost. 90: 167-184
41. Mulliken J. B. and Glowacki J. (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast. Reconstr. Surg. 69: 412-422
42. Mulliken J. B. (1993) Cutaneous vascular anomalies. Semin. Vasc. Surg. 6: 204-218
43. Enjolras O. and Mulliken J. B. (1997) Vascular tumors and vascular malformations (new issues). Adv. Dermatol. 13: 375-423
44. Vikkula M., Boon L. M., Mulliken J. B. and Olsen B. R. (1998) Molecular basis of vascular anomalies. Trends Cardiovasc. Med. 8: 281-292
45. Klippel M. and Trenaunay P. (1900) Du naevus variqueux osteo-hypertrophique. Arch. Gen. Med. 185: 641-672
46. Berry S. A., Peterson C., Mize W., Bloom K., Zachary C., Blasco P. et al. (1998) Klippel-Trenaunay syndrome. Am. J. Med. Genet. 79: 319-326
47. Jacob A. G., Driscoll D. J., Shaughnessy W. J., Stanson A. W., Clay R. P. and Gloviczki P. (1998) Klippel-Trenaunay syndrome: spectrum and management. Mayo Clin. Proc. 73: 28-36
48. Cohen M. M. Jr (2000) Klippel-Trenaunay syndrome. Am. J. Med. Genet. 93: 171-175
49. Lindenauer S. M. (1965) The Klippel-Trenaunay syndrome: varicosity, hypertrophy and hemangioma with no arteriovenous fistula. Ann. Surg. 162: 303-314
50. Gloviczki P., Stanson A. W., Stickler G. B., Johnson C. M., Toomey B. J., Meland N. B. et al. (1991) Klippel-Trenaunay syndrome: the risks and benefits of vascular interventions. Surgery 110: 469-479
51. Servelle M. (1985) Klippel and Trenaunay's syndrome. 768 operated cases. Ann. Surg. 201: 365-373
52. Gorenstein A., Katz S. and Schiller M. (1988) Congenital angiodysplasia of the superficial venous system of the lower extremities in children. Ann. Surg. 207: 213-218
53. Gorenstein A., Shifrin E., Gordon R. L., Katz S. and Schiller M. (1986) Congenital aplasia of the deep veins of lower extremities in children: the role of ascending functional phlebography. Surgery 99: 414-420
54. Paes E. H. and Vollmar J. F. (1990) Aneurysma transformation in congenital venous angiodysplasias in lower extremities. Int. Angiol. 9: 90-96
55. Aelvoet G. E., Jorens P. G. and Roelen L. M. (1992) Genetic aspects of the Klippel-Trenaunay syndrome. Br. J. Dermatol. 126: 603-607
56. Ceballos-Quintal J. M., Pinto-Escalante D. and Castillo-Zapata I. (1996) A new case of Klippel-Trenaunay-Weber (KTW) syndrome: evidence of autosomal dominant inheritance. Am. J. Med. Genet. 63: 426-427
57. Lorda-Sanchez I., Prieto L., Rodriguez-Pinilla E. and Martinez-Frias M. L. (1998) Increased parental age and number of pregnancies in Klippel-Trenaunay-Weber syndrome. Ann. Hum. Genet. 62: 235-239
58. Whelan A. J., Watson M. S., Porter F. D. and Steiner R. D. (1995) Klippel-Trenaunay-Weber syndrome associated with a 5:11 balanced translocation. Am. J. Med. Genet. 59: 492-494
59. Wang Q., Timur A. A., Szafranski P., Sadgephour A., Jurecic V., Cowell J. et al. (2001) Identification and molecular characterization of de novo translocation t(8;14)(q22.3;q13) associated with a vascular and tissue overgrowth syndrome. Cytogenet. Cell Genet. 95: 183-188
60. Timur A. A., Sadgephour A., Graf M., Schwartz S., Libby E. D., Driscoll D. J. et al. (2004) Identification and molecular characterization of a de novo supernumerary ring chromosome 18 in a patient with Klippel-Trenaunay syndrome. Ann. Hum. Genet. 68: 353-361
61. Tian X. L., Kadaba R., You S. A., Liu M., Timur A. A., Yang L. et al. (2004) Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 427: 640-645
62. Durocher D. and Jackson S. P. (2002) The FHA domain. FEBS Lett. 513: 58-66
63. Guglielmi B. and Werner M. (2002) The yeast homolog of human PinX1 is involved in rRNA and small nucleolar RNA maturation, not in telemore elongation inhibition. J. Biol. Chem. 277: 35712-35719
64. Callebaut I. and Mornon J. P. (2004) OCRE: a novel domain made of imperfect, aromatic-rich octamer repeats. Bioinformatics. [Epub ahead of print]
65. Baskerville P. A., Ackroyd J. S. and Browse N.L. (1985) The etiology of the Klippel-Trenaunay syndrome. Ann. Surg. 202: 624-627
66. Fontana A. and Olivetti L. (2004) Peripheral MR angiography of Klippel-Trenaunay syndrome. Cardiovasc. Intervent. Radiol. 27: 297-299
67. Happle R. (1986) Cutaneous manifestation of lethal genes. Hum. Genet. 72: 280
68. Happle R. (1987) Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J. Am. Acad. Dermatol. 16: 899-906
69. Happle R. (1993) Klippel-Trenaunay syndrome: is it a paradominant trait? Br. J. Dermatol. 128: 465-466
70. Vikkula M., Boon L. M., Carraway K. L. III, Calvert J. T., Diamonti A. J., Goumnerov B. et al. (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87: 1181-1190
71. Karkkainen M. J., Ferrell R. E., Lawrence E. C., Kimak M. A., Levinson K. L., McTigue M. A. et al. (2000) Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet. 25: 153-159
72. Jacobs A. H. and Walton R. G. (1976) The incidence of birthmarks in the neonate. Pediatrics 58: 218-222
73. Eerola I., Boon L. M., Mulliken J. B., Burrows P. E., Dompmartin A., Watanabe S. et al. (2003) Capillary malformation arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am. J. Hum. Genet. 73: 1240-1249
74. Gibbs J. B., Marshall M. S., Scolnick E. M., Dixon R. A. and Vogel U. S. (1990) Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors and the GTPase activating protein (GAP). J. Biol. Chem. 265: 20437-20442
75. Clark G. J., Quilliam L. A., Hisaka M. M. and Der C. J. (1993) Differential antagonism of Ras biological activity by catalytic and Src homology domains of Ras GTPase activation protein. Proc. Natl. Acad. Sci. USA 90: 4887-4891
76. Settleman J., Narasimhan V., Foster L. C. and Weinberg R. A. (1992) Molecular cloning of cDNAs encoding the GAP-associated protein p190: implications for a signaling pathway from ras to the nucleus. Cell 69: 539-549
77. Caron E., Self A. J. and Hall A. (2000) The GTPase Rap1 controls functional activation of macrophage integrin alpha-Mbeta2 by LPS and other inflammatory mediators. Curr. Biol. 10: 974-978
78. Reedquist K. A., Ross E., Koop E. A., Wolthuis R. M., Zwartkruis F. J., van K.Y. et al. (2000) The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J. Cell Biol. 148: 1151-1158
79. Parkes Weber F. (1907) Angioma formation in connection with hypertrophy of limbs and hemihypertrophy. Br. J. Dermatol. 19: 231
80. Mulliken J. B. and Young A. E. (eds) (1988) Vascular Birthmarks: Hemangiomas and Vascular Malformations. W. B. Saunders, Philadelphia
81. Cohen M. M. Jr (2002) Vasculogenesis, angiogenesis, hemangiomas and vascular malformations. Am. J. Med. Genet. 108: 265-274
82. Laberge-Le C. S., Jung H. H., Labauge P., Houtteville J. P., Lescoat C., Cecillon M. et al. (1999) Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat. Genet. 23: 189-193
83. Sahoo T., Johnson E. W., Thomas J. W., Kuehl P. M., Jones T. L., Dokken C. G. et al. (1999) Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum. Mol. Genet. 8: 2325-2333
84. Serebriiskii I., Estojak J., Sonoda G., Testa J. R. and Golemis E. A. (1997) Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 15: 1043-1049
85. Kitayama H., Sugimoto Y., Matsuzaki T., Ikawa Y. and Noda M. (1989) A ras-related gene with transformation suppressor activity. Cell 56: 77-84
86. Zawistowski J. S., Serebriiskii I. G., Lee M. F., Golemis E. A. and Marchuk D. A. (2002) KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum. Mol. Genet. 11: 389-396
87. Eerola I., Plate K. H., Spiegel R., Boon L. M., Mulliken J. B. and Vikkula M. (2000) KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum. Mol. Genet. 9: 1351-1355
88. Denier C., Goutagny S., Labauge P., Krivosic V., Arnoult M., Cousin A. et al. (2004) Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 74: 326-337
89. Liquori C. L., Berg M. J., Siegel A. M., Huang E., Zawistowski J. S., Stoffer T. et al. (2003) Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am. J. Hum. Genet. 73: 1459-1464
90. Bergametti F., Denier C., Labauge P., Arnoult M., Boetto S., Clanet M. et al. (2004) Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 76: 42-51
91. Brouillard P., Boon L. M., Mulliken J. B., Enjolras O., Ghassibe M., Warman M. L. et al. (2002) Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ('glomangiomas'). Am. J. Hum. Genet. 70: 866-874
92. Fang J., Dagenais S. L., Erickson R. P., Arlt M. F., Glynn M. W., Gorski J. L. et al. (2000) Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet. 67: 1382-1388
93. Doffinger R., Smahi A., Bessia C., Geissmann F., Feinberg J., Durandy A. et al. (2001) X-linked anhidrotic ectodermal dysplasia with immunodeficiency caused by impaired NF-kappaB signaling. Nat. Genet. 27: 277-285
94. Irrthum A., Devriendt K., Chitayat D., Matthijs G., Glade C., Steijlen P. M. et al. (2003) Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am. J. Hum. Genet. 72: 1470-1478
95. McAllister K. A., Grogg K. M., Johnson D. W., Gallione C. J., Baldwin M. A., Jackson C. E. et al. (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 8: 345-351
96. Johnson D. W., Berg J. N., Baldwin M. A., Gallione C. J., Marondel I., Yoon S. J. et al. (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet. 13: 189-195
97. Gallione C. J., Repetto G. M., Legius E., Rustgi A. K., Schelley S. L., Tejpar S. et al. (2004) A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363: 852-859
98. Black G. C., Perveen R., Bonshek R., Cahill M., Clayton-Smith J., Lloyd I. C. et al. (1999) Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum. Mol. Genet. 8: 2031-2035
99. Black G. and Redmond R. M. (1994) The molecular biology of Norrie's disease. Eye 8: 491-496
100. Meitinger T., Meindl A., Bork P., Rost B., Sander C., Haasemann M. et al. (1993) Molecular modelling of the Norrie disease protein predicts a cystine knot growth factor tertiary structure. Nat. Genet. 5: 376-380
101. Sorsby A. (1949) A fundus dystrophy with unusual features (late onset and dominant inheritance of a central retinal lesion showing oedema, haemorrhage and exudates developing into generalized choroidal atrophy with massive pigment proliferation). Brit. J. Opthal. 33: 67-97
102. Weber B. H. (1994) Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat. Genet. 8: 352-356
103. Qi J.H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L., Bond M. et al. (2003) A novel function for tissue inhibitor of metalloproteninases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 9: 407-415
104. Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P. et al. (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383: 707-710
105. Superti-Furga A., Gugler E., Gitzelmann R. and Steinmann B. (1988) Ehlers-Danlos syndrome type IV: a multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability and processing of type III procollagen. J. Biol. Chem. 263: 6226-6232
106. Hoeger P. H., Martinez A., Maerker J. and Harper J. I. (2004) Vascular anomalies in Proteus syndrome. Clin. Exp. Dermatol. 29: 222-230
107. Eng C. (2003) PTEN: one gene, many syndromes. Hum. Mutat. 22: 183-198
108. Zhou X. P., Marsh D. J., Hampel H., Mulliken J. B., Gimm O. and Eng C. (2000) Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis. Hum. Mol. Genet. 9: 765-768
109. Zhou X., Hampel H., Thiele H., Gorlin R. J., Hennekam R. C., Parisi M. et al. (2001) Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet 358: 210-211
110. Smith J. M., Kirk E. P., Theodosopoulos G., Marshall G. M., Walker J., Rogers M. et al. (2002) Germline mutation of the tumour suppressor PTEN in Proteus syndrome. J. Med. Genet. 39: 937-940
111. Nelen M. R., van Staveren W. C., Peeters E. A., Hassel M. B., Gorlin R. J., Hamm H. et al. (1997) Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum. Mol. Genet. 6: 1383-1387
112. Marsh D. J., Dahia P. L., Zheng Z., Liaw D., Parsons R., Gorlin R. J. et al. (1997) Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet. 16: 333-334